• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK VANTUS; PROTHROMBIN TIME MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK VANTUS; PROTHROMBIN TIME MONITOR Back to Search Results
Model Number COAGUCHEK INRANGE
Device Problems Circuit Failure (1089); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 05/08/2022
Event Type  Injury  
Event Description
There was an allegation of coaguchek vantus meter error messages that prohibited the patient from being able to perform inr tests.Reportedly the patient had a clot in her neck and is in the hospital.The reporter alleged they had a measurement of 3.8 inr on (b)(6) 2022.The returned meter memory confirmed a measurement of 3.8 inr on (b)(6) 2022 at 04:25 a.M.The patient's warfarin dosage was decreased by 1 mg.The test strip lot number was 56561321 with an expiration date of 31-may-2023.After the reading of 3.8 inr, additional attempts were allegedly made to test on (b)(6) 2022 and it was reported the coaguchek vantus meter showed an m-31 message.The reporter confirmed the battery compartment was clean and dry.For message m-31, product labeling states, "batteries empty: batteries are nearly empty.Replace batteries now." reportedly the meter's batteries were replaced and the battery contacts were cleaned, but the issue persisted.The reporter stated the meter's batteries were replaced again but the meter displayed an error message e-63.For e-63, product labeling states, "meter error: hardware or electronic error.Power meter off and on.If error persists, contact roche diagnostics." (b)(6) 2022 was believed to be the last time the patient attempted to use the meter.On (b)(6) 2022, allegedly the patient's hands and feet began to swell.On (b)(6) 2022, it was reported the patient was advised by her physician to go to the emergency room (er).Allegedly the patient went to the er and a clot was discovered in the patient's neck.The reporter "thinks" the left ventricular was blocked and "believes" the hospital inr result was in the "1.0's" when admitted.Reportedly the patient was taken off warfarin and was administered a heparin drip intravenously (iv).It was reported that "they do not know what caused the clot to form." reportedly the patient did not suffer a stroke and did not require surgery.The type of tests performed on the patient is unknown.Reportedly "the blood clot has dissolved and the patient is still currently in the hospital." allegedly the patient will be discharged once the inr levels reach the therapeutic range and she will be sent home with lovenox injections.The patient's therapeutic range was 2.5-3.0 inr.The patient's testing frequency is weekly.
 
Manufacturer Narrative
The reporter's meter and test strips were provided for investigation where they were tested using retention controls.Replacement product was sent.Testing results (qc range = 4.1 - 6.8 inr): qc 1: 5.0 inr.Qc 2: 5.0 inr.Qc 3: 4.9 inr.The error messages, m-31 and e-63, were resolved with the use of retention batteries during the investigation.The meter was able to be successfully tested and no error messages occurred during the investigation.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.The investigation did not identify a product problem.The cause of the event could not be determined.Occupation is patient's daughter/consumer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK VANTUS
Type of Device
PROTHROMBIN TIME MONITOR
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14648686
MDR Text Key294886279
Report Number1823260-2022-01680
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702700499
UDI-Public00365702700499
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberCOAGUCHEK INRANGE
Device Catalogue Number07729952160
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/26/2022
Date Manufacturer Received05/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMLODIPINE; ATORVASTATIN; DOCUSATE SODIUM; FAMOTIDINE; LOSARTAN; METHOTREXATE; METOPROLOL; TRAMADOL; TYLENOL; VITAMIN D2; WARFARIN
Patient Outcome(s) Other; Hospitalization;
Patient Age69 YR
Patient SexFemale
Patient Weight59 KG
-
-